These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 25661387)
1. Soluplus(®) micelles as a potential drug delivery system for reversal of resistant tumor. Jin X; Zhou B; Xue L; San W Biomed Pharmacother; 2015 Feb; 69():388-95. PubMed ID: 25661387 [TBL] [Abstract][Full Text] [Related]
2. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance. Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761 [TBL] [Abstract][Full Text] [Related]
3. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells. Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559 [TBL] [Abstract][Full Text] [Related]
4. Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance. Wang J; Sun J; Chen Q; Gao Y; Li L; Li H; Leng D; Wang Y; Sun Y; Jing Y; Wang S; He Z Biomaterials; 2012 Oct; 33(28):6877-88. PubMed ID: 22770799 [TBL] [Abstract][Full Text] [Related]
5. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice. Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307 [TBL] [Abstract][Full Text] [Related]
6. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin. Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738 [TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of a novel drug delivery: Soluplus Ding Y; Wang C; Wang Y; Xu Y; Zhao J; Gao M; Ding Y; Peng J; Li L Drug Dev Ind Pharm; 2018 Sep; 44(9):1409-1416. PubMed ID: 29718714 [TBL] [Abstract][Full Text] [Related]
8. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles. Yu P; Yu H; Guo C; Cui Z; Chen X; Yin Q; Zhang P; Yang X; Cui H; Li Y Acta Biomater; 2015 Mar; 14():115-24. PubMed ID: 25498306 [TBL] [Abstract][Full Text] [Related]
9. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. Lee ES; Na K; Bae YH J Control Release; 2005 Mar; 103(2):405-18. PubMed ID: 15763623 [TBL] [Abstract][Full Text] [Related]
10. pH-responsive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly(D,L-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor. Zhao Y; Zhou Y; Wang D; Gao Y; Li J; Ma S; Zhao L; Zhang C; Liu Y; Li X Acta Biomater; 2015 Apr; 17():182-92. PubMed ID: 25612838 [TBL] [Abstract][Full Text] [Related]
11. Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines. Bernabeu E; Gonzalez L; Cagel M; Gergic EP; Moretton MA; Chiappetta DA Colloids Surf B Biointerfaces; 2016 Apr; 140():403-411. PubMed ID: 26780253 [TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance. Jin X; Mo R; Ding Y; Zheng W; Zhang C Mol Pharm; 2014 Jan; 11(1):145-57. PubMed ID: 24261922 [TBL] [Abstract][Full Text] [Related]
13. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells. Wang TX; Yang XH Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331 [TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine. Jin J; Wang FP; Wei H; Liu G Cancer Chemother Pharmacol; 2005 Feb; 55(2):179-88. PubMed ID: 15378274 [TBL] [Abstract][Full Text] [Related]
15. Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy. Chen L; Ji F; Bao Y; Xia J; Guo L; Wang J; Li Y Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):418-429. PubMed ID: 27770912 [TBL] [Abstract][Full Text] [Related]
16. Soluplus/TPGS mixed micelles for dioscin delivery in cancer therapy. Zhao J; Xu Y; Wang C; Ding Y; Chen M; Wang Y; Peng J; Li L; Lv L Drug Dev Ind Pharm; 2017 Jul; 43(7):1197-1204. PubMed ID: 28300426 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles. Hu FQ; Liu LN; Du YZ; Yuan H Biomaterials; 2009 Dec; 30(36):6955-63. PubMed ID: 19782395 [TBL] [Abstract][Full Text] [Related]
18. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor. Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286 [TBL] [Abstract][Full Text] [Related]
19. Transferrin receptor-targeted pH-sensitive micellar system for diminution of drug resistance and targetable delivery in multidrug-resistant breast cancer. Gao W; Ye G; Duan X; Yang X; Yang VC Int J Nanomedicine; 2017; 12():1047-1064. PubMed ID: 28223798 [TBL] [Abstract][Full Text] [Related]
20. Reversal of doxorubicin resistance by guggulsterone of Commiphora mukul in vivo. Xu HB; Shen ZL; Fu J; Xu LZ Phytomedicine; 2014 Sep; 21(11):1221-9. PubMed ID: 25172783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]